1. Home
  2. RELY vs SUPN Comparison

RELY vs SUPN Comparison

Compare RELY & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Remitly Global Inc.

RELY

Remitly Global Inc.

HOLD

Current Price

$16.75

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$55.98

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELY
SUPN
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
RELY
SUPN
Price
$16.75
$55.98
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$24.13
$61.60
AVG Volume (30 Days)
4.5M
783.2K
Earning Date
05-20-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
263.16
6500.00
EPS
0.31
N/A
Revenue
$1,635,147,000.00
$392,755,000.00
Revenue This Year
$19.99
$8.18
Revenue Next Year
$18.40
$22.15
P/E Ratio
$52.42
N/A
Revenue Growth
29.37
N/A
52 Week Low
$12.08
$29.16
52 Week High
$24.63
$59.68

Technical Indicators

Market Signals
Indicator
RELY
SUPN
Relative Strength Index (RSI) 68.40 69.58
Support Level $15.17 $47.95
Resistance Level $17.39 $57.65
Average True Range (ATR) 0.76 2.03
MACD 0.38 0.57
Stochastic Oscillator 78.79 63.80

Price Performance

Historical Comparison
RELY
SUPN

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: